Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy (Q66077639)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy |
clinical trial |
Statements
A Randomized Trial of Sirolimus (Rapamune) for Relapse Prevention in Patients With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy (English)
0 references
19 December 2016
0 references
31 August 2023
0 references
118
0 references
2 year
0 references
99 year
0 references